Markets ended positive this Thursday with 50-share Nifty closing above key resistance level of 5,900 on the final day of April derivatives expiry. The Nifty ended (provisional) at 5,917 - up 80 points. The Sensex ended at 19,398 - up 218 points.
_________________________________
(Updated at 1435 hrs)
Benchmark indices continue to trade higher led by buying demand auto, oil and gas and metal shares.
By 1435, Sensex surged by 130 points at 19,308, and the Nifty was up 49 points at 5,885 levels.
On the global front, Asian shares rose on Thursday, with recovering commodities and views that a run of weak global economic data will encourage major central banks to keep or deepen their monetary stimulus improving risk sentiment, but weak data undermined the dollar.
Back home, the rupee gained by 19 paise to 54.19 against the American currency in the late morning trade on fresh selling of dollars by banks on the back of weakness of dollar in overseas market.
Meanwhile, the meeting of the joint parliamentary committee (JPC) on 2G spectrum allocation to finalise its draft report has been postponed, sources said Thursday.
On the sectoral front, BSE Auto, Oil & Gas and Metal indices have surged by 2% each followed by counters like Healthcare, Banks, PSU and Power, all gaining by 1% each. However, BSE IT and Consumer Durable indices have declined by 1% each.
The main gainers on the Sensex at this hour include Dr Reddy’s Lab, Tata Motors, Sterlite, Maruti Suzuki and NTPC, all surging between 3-5%.
Dr Reddy’s Laboratories is trading higher by 4.69% at Rs 1,992, also its record high on the National Stock Exchange (NSE).
The pharmaceutical stock has outperformed the market by surging 13% in past one month after the company settled its claims against Ottawa headquartered Nordion Inc. (formerly MDS Inc.) in a case pending in a district court of New Jersey in the US, for a cash payment of $ 22.5 million by Nordion to Dr Reddy’s Lab.
On the losing side, Wipro, TCS, HUL and Infosys have declined between 1-3%.
The market breadth in BSE remains healthy 1,200 shares advancing and 1,081 shares declining.
_________________________________
(Updated at 1435 hrs)
Benchmark indices continue to trade higher led by buying demand auto, oil and gas and metal shares.
Also Read
Indian investors are trading cautiously ahead of May 3rd monetary policy amid expectations that the Reserve Bank of India may cut interest rates by 25-50 basis points as WPI inflation eased.
By 1435, Sensex surged by 130 points at 19,308, and the Nifty was up 49 points at 5,885 levels.
On the global front, Asian shares rose on Thursday, with recovering commodities and views that a run of weak global economic data will encourage major central banks to keep or deepen their monetary stimulus improving risk sentiment, but weak data undermined the dollar.
Back home, the rupee gained by 19 paise to 54.19 against the American currency in the late morning trade on fresh selling of dollars by banks on the back of weakness of dollar in overseas market.
Meanwhile, the meeting of the joint parliamentary committee (JPC) on 2G spectrum allocation to finalise its draft report has been postponed, sources said Thursday.
On the sectoral front, BSE Auto, Oil & Gas and Metal indices have surged by 2% each followed by counters like Healthcare, Banks, PSU and Power, all gaining by 1% each. However, BSE IT and Consumer Durable indices have declined by 1% each.
The main gainers on the Sensex at this hour include Dr Reddy’s Lab, Tata Motors, Sterlite, Maruti Suzuki and NTPC, all surging between 3-5%.
Dr Reddy’s Laboratories is trading higher by 4.69% at Rs 1,992, also its record high on the National Stock Exchange (NSE).
The pharmaceutical stock has outperformed the market by surging 13% in past one month after the company settled its claims against Ottawa headquartered Nordion Inc. (formerly MDS Inc.) in a case pending in a district court of New Jersey in the US, for a cash payment of $ 22.5 million by Nordion to Dr Reddy’s Lab.
On the losing side, Wipro, TCS, HUL and Infosys have declined between 1-3%.
The market breadth in BSE remains healthy 1,200 shares advancing and 1,081 shares declining.
)